A top-5 pharmaceutical company required support in in developing compelling messages on the socioeconomic value of new treatments for geographic atrophy.
Shift Health’s Role
Shift Health conducted an exhaustive survey of the scientific and clinical literature on geographic atrophy to understand the volume and quality of existing data. We supplemented secondary research with consultations with payers and ophthalmologists to gather perspectives on the socioeconomic value of new treatments for geographic atrophy. Shift Health developed a detailed report that presented a high-level synthesis of the most compelling data and outlined a set of preliminary evidence-based messages.
The client was armed with a foundational evidence base to substantiate compelling messages and communication material enabling effective dialogue with decision-makers.